The clinical significance of the glucocorticoid receptors: Genetics and epigenetics

R Motavalli, T Majidi, T Pourlak, S Abediazar… - The Journal of Steroid …, 2021 - Elsevier
The impacts of glucocorticoids (GCs) are mainly mediated by a nuclear receptor (GR)
existing in almost every tissue. The GR regulates a wide range of physiological functions …

Glucocorticoid resistance as a major drive in sepsis pathology

K Dendoncker, C Libert - Cytokine & growth factor reviews, 2017 - Elsevier
Sepsis is an acute systemic inflammatory disease. Glucocorticoids (GCs), which function by
binding to the GC receptor GR have very powerful anti-inflammatory activities, yet they are …

Advances in autoimmune myasthenia gravis management

S Wang, I Breskovska, S Gandhy… - Expert review of …, 2018 - Taylor & Francis
Introduction: Myasthenia gravis (MG) is an autoimmune neuromuscular disorder with no
cure and conventional treatments limited by significant adverse effects and variable benefit …

Corticosteroid treatment-resistance in myasthenia gravis

HJ Kaminski, J Denk - Frontiers in neurology, 2022 - frontiersin.org
Chronic, high-dose, oral prednisone has been the mainstay of myasthenia gravis treatment
for decades and has proven to be highly beneficial in many, toxic in some way to all, and not …

Novel treatment strategies for acetylcholine receptor antibody-positive myasthenia gravis and related disorders

M Mané-Damas, PC Molenaar, P Ulrichts… - Autoimmunity …, 2022 - Elsevier
The presence of autoantibodies directed against the muscle nicotinic acetylcholine receptor
(AChR) is the most common cause of myasthenia gravis (MG). These antibodies damage …

[PDF][PDF] Myasthenia gravis: the future is here

HJ Kaminski, P Sikorski, SI Coronel… - Journal of Clinical …, 2024 - Am Soc Clin Investig
Myasthenia gravis (MG) stands as a prototypical antibody-mediated autoimmune disease: it
is dependent on T cells and characterized by the presence of autoantibodies targeting …

The relationship between occupational stress and job burnout in coal miners: interactions between GCCR and SLC6A4 gene polymorphisms and the environment

X Yi, X Li, X Ma, F Li - Journal of affective disorders, 2022 - Elsevier
Objective To understand the current situation of job burnout among coal miners in **njian.
The effects of occupational stress, GCCR and SLC6A4 gene polymorphisms, and gene …

Serum metabolomics of treatment response in myasthenia gravis

P Sikorski, Y Li, M Cheema, GI Wolfe, LL Kusner… - Plos one, 2023 - journals.plos.org
Objective High-dose prednisone use, lasting several months or longer, is the primary initial
therapy for myasthenia gravis (MG). Upwards of a third of patients do not respond to …

NR3C1 Glucocorticoid Receptor Gene Polymorphisms Are Associated with Membranous and IgA Nephropathies

M Pac, N Krata, B Moszczuk, A Wyczałkowska-Tomasik… - Cells, 2021 - mdpi.com
Glomerular diseases (GNs) are responsible for approximately 20% of chronic kidney
diseases. Glucocorticoid receptor gene (NR3C1) single nucleotide polymorphisms (SNPs) …

Age of onset and factors affecting treatment responses in ocular myasthenia gravis

P Kemchoknatee, A Armornpetchsathaporn… - International …, 2023 - Springer
Background Ocular myasthenia gravis (OMG) is an autoimmune disease which causes
ptosis, diplopia, or both. It can be categorized as early or late onset, with differing presenting …